RONA DELLINGER: Open Payments
NPI 1275537045 · MENDON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,294 in 64 payments from 14 companies in 2025. Trend: 2023 $1,620 · 2024 $1,358 · 2025 $1,294
Food & beverage: $1,294
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $390 |
| ABBVIE INC. | 13 | $293 |
| Lilly USA, LLC | 9 | $163 |
| Novo Nordisk Inc | 9 | $142 |
| Insulet Corporation | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| PFIZER INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Amgen Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $27 |
Products named: VRAYLAR, AIRSUPRA, MOUNJARO, BREZTRI, FARXIGA, Omnipod, LEQVIO, Ozempic.
Industry payments across OH — which companies pay providers there.
